Oncorena
Lund
About Oncorena
Oncorena is a pharmaceutical company that is working on a treatment for advanced kidney cancer (metastatic renal cancer). Its goal is to confirm orellanine's potent anti-tumor activity and other clinical benefits in patients with advanced kidney cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $22.9M
- Last round: Series Unknown (Jun 2025)
- Website: oncorena.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oncorena-79468 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.